Daniel J Farkas Selected Research

Daniel J Farkas Research Topics

4	Pain (Aches) 09/2023 - 01/2021
3	Neuralgia (Stump Neuralgia) 09/2023 - 01/2020
3	Peripheral Nervous System Diseases (PNS Diseases) 09/2023 - 01/2021
2	Hypersensitivity (Allergy) 09/2023 - 12/2022
2	Hyperalgesia 12/2022 - 01/2020
1	Chronic Pain 07/2023
1	Cerebellar Ataxia (Dysmetria) 01/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Nociceptive Pain 01/2021

4	mitragynineIBA 09/2023 - 01/2020
4	AlkaloidsIBA 09/2023 - 01/2020
4	Opioid Analgesics (Opioids)IBA 09/2023 - 01/2020
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2023 - 01/2020
2	CannabinoidsIBA 09/2023 - 07/2023
2	Opioid Receptors (Opioid Receptor)IBA 12/2022 - 01/2022
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2022 - 01/2020
2	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2022 - 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2023
1	Formaldehyde (Formol)FDA Link 09/2023
1	Riluzole FDA LinkGeneric 01/2023
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	D-Ala-peptide T-amideIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	RAP-103IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	CannabidiolIBA 01/2021